Kingdom Stock: price and insider trades · Saudi Arabia
Kingdom: what insiders have been doing
Insider filings for Kingdom are scarce in the Tadawul (CMA) feed, the latest one published on 22 May 2022. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by Tadawul (CMA). They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 13,001 of 26,897 companies
52.3
score / 100
Value44
Quality61
FCF yld1.1%
Earn yld4.4%
EV/EBITDA18.4x
ROE3.4%
Gross mgn59%
Net mgn80%
Debt/EBITDA3.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SAR 13.08
Analyst consensus
1 analysts4.00/5
SAR 14.00Target SAR 14.00(+7%)SAR 14.00
Income statement
RevenueSAR 2.7B
Gross profitSAR 1.6B59% margin
EBITDASAR 3.3B124% margin
Net incomeSAR 2.1B75.4% margin
Valuation
PER (trailing)25.6x
PER (forward)40.9x
P/Book0.7x
Beta0.16
Balance sheet & cash
Market capSAR 48.5B
Total debtSAR 12.8B
Free Cash FlowSAR 550.2M
Debt / Equity18%
Profitability & ownership
ROE3.4%
ROA0.9%
% insiders78.1%
% institutions17.2%
Last declaration on 22 May 2022
Declarations1 total
- ●Executives0Tadawul
1 of 1 declaration
About Kingdom
Kingdom is a company operating in the health and pharmaceutical sector. It is listed on the XSAU market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations